(GIVN) Givaudan - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0010645932

GIVN: Fragrance, Beauty, Taste, Wellbeing

Givaudan SA is the global leader in the creation, manufacture, and supply of fragrance, beauty, taste, and wellbeing products for the consumer goods industry. With a legacy dating back to 1796, the company operates at the intersection of science and creativity, serving clients across Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Its portfolio spans fine fragrances, personal care products, flavor solutions, and active beauty ingredients, making it a critical partner for global brands seeking innovative sensory experiences.

The company is organized into two core divisions: Fragrance & Beauty and Taste & Wellbeing. The Fragrance & Beauty division develops fragrances for perfumes, personal care items, and household products, alongside active beauty solutions that enhance skincare efficacy. The Taste & Wellbeing division specializes in flavor technologies for beverages, dairy products, snacks, confectionery, and savory goods, while also offering nutraceuticals and supplements that align with consumer trends toward health and wellness.

Givaudan SA is listed on the SIX Swiss Exchange under the ticker symbol GIVN. With a market capitalization of 34,856.77M CHF, the company is classified under the Specialty Chemicals sub-industry. Its financial performance reflects a price-to-earnings ratio of 32.15, with a forward P/E of 28.33, indicating expectations of continued growth. The company’s return on equity stands at 41.44%, underscoring its operational efficiency and profitability.

Based on the provided technical and fundamental data, here is a 3-month forecast for Givaudan SA: - Month 1: The stock is likely to experience a downtrend, as the last price (3778.00) is below the SMA 200 (4026.30). Support levels may be tested, with potential volatility indicated by an ATR of 104.53. - Month 2: The stock could stabilize near the SMA 50 level (3846.21), with price movements influenced by the company’s high P/S ratio (4.70) and strong ROE (41.44%). - Month 3: A potential recovery could emerge, driven by the company’s fundamentals, particularly its leadership in the specialty chemicals sector and its ability to maintain high profitability despite elevated valuations (P/B: 7.61).

Additional Sources for GIVN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

GIVN Stock Overview

Market Cap in USD 42,149m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

GIVN Stock Ratings

Growth Rating 2.39
Fundamental 80.4
Dividend Rating 51.2
Rel. Strength 6.09
Analysts -
Fair Price Momentum 3767.52 CHF
Fair Price DCF 4587.69 CHF

GIVN Dividends

Dividend Yield 12m 1.75%
Yield on Cost 5y 2.40%
Annual Growth 5y 1.86%
Payout Consistency 97.3%

GIVN Growth Ratios

Growth Correlation 3m -34%
Growth Correlation 12m -66%
Growth Correlation 5y 13.7%
CAGR 5y 6.42%
CAGR/Max DD 5y 0.15
Sharpe Ratio 12m 0.66
Alpha -1.98
Beta 0.078
Volatility 27.21%
Current Volume 26k
Average Volume 20d 20k
What is the price of GIVN stocks?
As of May 02, 2025, the stock is trading at CHF 3982.00 with a total of 25,968 shares traded.
Over the past week, the price has changed by +3.67%, over one month by +4.16%, over three months by +3.30% and over the past year by +2.36%.
Is Givaudan a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Givaudan (SW:GIVN) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 80.42 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GIVN as of May 2025 is 3767.52. This means that GIVN is currently overvalued and has a potential downside of -5.39%.
Is GIVN a buy, sell or hold?
Givaudan has no consensus analysts rating.
What are the forecast for GIVN stock price target?
According to ValueRays Forecast Model, GIVN Givaudan will be worth about 4068.9 in May 2026. The stock is currently trading at 3982.00. This means that the stock has a potential upside of +2.18%.
Issuer Forecast Upside
Wallstreet Target Price 4159.7 4.5%
Analysts Target Price - -
ValueRay Target Price 4068.9 2.2%